Axa S.A. Catalyst Biosciences, Inc. Transaction History

Axa S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.91 - $9.31 $57,447 - $108,927	-11,700 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$7.08 - $10.6 $122,484 - $183,380	-17,300 Reduced 59.66%	11,700 $86,000
Q2 2018 Aug 13, 2018	BUY	$9.11 - $28.88 $264,190 - $837,520	29,000 New	29,000 $338,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.